Seres Therapeutics Inc (MCRB)
1.01
-0.01
(-0.98%)
USD |
NASDAQ |
May 10, 16:00
1.01
0.00 (0.00%)
After-Hours: 19:55
Seres Therapeutics Net Income (TTM): -113.72M for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -113.72M |
| September 30, 2023 | -141.27M |
| June 30, 2023 | -153.42M |
| March 31, 2023 | -264.71M |
| December 31, 2022 | -250.16M |
| September 30, 2022 | -231.36M |
| June 30, 2022 | -103.14M |
| March 31, 2022 | -86.74M |
| December 31, 2021 | -65.58M |
| September 30, 2021 | -33.83M |
| June 30, 2021 | -132.33M |
| March 31, 2021 | -104.71M |
| December 31, 2020 | -89.13M |
| September 30, 2020 | -89.65M |
| June 30, 2020 | -75.78M |
| March 31, 2020 | -65.83M |
| December 31, 2019 | -70.28M |
| September 30, 2019 | -72.79M |
| June 30, 2019 | -78.33M |
| Date | Value |
|---|---|
| March 31, 2019 | -95.36M |
| December 31, 2018 | -98.94M |
| September 30, 2018 | -106.61M |
| June 30, 2018 | -91.59M |
| March 31, 2018 | -91.82M |
| December 31, 2017 | -89.38M |
| September 30, 2017 | -85.70M |
| June 30, 2017 | -97.46M |
| March 31, 2017 | -97.35M |
| December 31, 2016 | -91.58M |
| September 30, 2016 | -85.94M |
| June 30, 2016 | -81.87M |
| March 31, 2016 | -66.51M |
| December 31, 2015 | -54.78M |
| September 30, 2015 | -43.33M |
| June 30, 2015 | -32.87M |
| March 31, 2015 | -22.99M |
| December 31, 2014 | -16.71M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-264.71M
Minimum
Mar 2023
-33.83M
Maximum
Sep 2021
-116.99M
Average
-89.65M
Median
Sep 2020
Net Income (TTM) Benchmarks
| Integra Lifesciences Holdings Corp | 40.23M |
| Nuwellis Inc | -20.21M |
| Axogen Inc | -21.28M |
| Axsome Therapeutics Inc | -296.38M |
| 908 Devices Inc | -34.78M |